Researchers at the University of Hong Kong have developed a novel nasal spray, NanoPowder, designed to deliver neurotherapeutic agents directly to the brain for rapid ischemic stroke treatment. This innovation, utilizing nano-in-micron technology to bypass the blood-brain barrier, aims to significantly reduce brain damage and improve survival rates. Clinical trials are anticipated by 2030, with potential applications for paramedics, high-risk groups, and eventually the general public. AI
排序理由 Academic research from a university lab developing a novel therapeutic. [lever_c_demoted from research: ic=1 ai=0.0]
- Aviva Chow Shing-fung
- International Exhibition of Inventions Geneva
- NanoPowder
- University of Hong Kong
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →